{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:07:13Z","timestamp":1793725633320,"version":"4.6.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Malaysia Ministry of Higher Education","doi-asserted-by":"crossref","award":["FRGS\/1\/2019\/SKK08\/UKM\/01\/4"],"award-info":[{"award-number":["FRGS\/1\/2019\/SKK08\/UKM\/01\/4"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s12035-020-02083-1","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T06:03:08Z","timestamp":1598853788000},"page":"5193-5207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Antioxidant Modulation of mTOR and Sirtuin Pathways in Age-Related Neurodegenerative Diseases"],"prefix":"10.1007","volume":"57","author":[{"given":"Asmaa","family":"Abdullah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuraqila","family":"Mohd Murshid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5239-6196","authenticated-orcid":false,"given":"Suzana","family":"Makpol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,31]]},"reference":[{"issue":"5","key":"2083_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.exger.2006.03.004","volume":"41","author":"AR Hipkiss","year":"2006","unstructured":"Hipkiss AR (2006) Accumulation of altered proteins and ageing: causes and effects. Exp Gerontol 41(5):464\u2013473","journal-title":"Exp Gerontol"},{"key":"2083_CR2","doi-asserted-by":"publisher","unstructured":"L\u00e1zaro DF, Bellucci A, Brundin P, Outeiro TF (2020) Editorial: protein misfolding and spreading pathology in neurodegenerative diseases. Front Mol Neurosci 12 (312). doi:https:\/\/doi.org\/10.3389\/fnmol.2019.00312","DOI":"10.3389\/fnmol.2019.00312"},{"key":"2083_CR3","doi-asserted-by":"crossref","unstructured":"Agbas A (2018) Trends of protein aggregation in neurodegenerative diseases. In: Neurochemical basis of brain function and dysfunction. IntechOpen","DOI":"10.5772\/intechopen.81224"},{"issue":"6","key":"2083_CR4","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM (2017) mTOR signaling in growth, metabolism, and disease. Cell 168(6):960\u2013976","journal-title":"Cell"},{"key":"2083_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bbr.2017.04.041","volume":"329","author":"LE Salminen","year":"2017","unstructured":"Salminen LE, Schofield PR, Pierce KD, Bruce SE, Griffin MG, Tate DF, Cabeen RP, Laidlaw DH et al (2017) Vulnerability of white matter tracts and cognition to the SOD2 polymorphism: a preliminary study of antioxidant defense genes in brain aging. Behav Brain Res 329:111\u2013119","journal-title":"Behav Brain Res"},{"issue":"12","key":"2083_CR6","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1080\/10715760600918142","volume":"40","author":"ER Stadtman","year":"2006","unstructured":"Stadtman ER (2006) Protein oxidation and aging. Free Radic Res 40(12):1250\u20131258","journal-title":"Free Radic Res"},{"issue":"9","key":"2083_CR7","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"C G-f","year":"2017","unstructured":"G-f C, Xu T-h, Yan Y, Y-r Z, Jiang Y, Melcher K, Xu HE (2017) Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin 38(9):1205\u20131235","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"2083_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2174\/1567205012666141218140953","volume":"12","author":"RJ Baranello","year":"2015","unstructured":"Baranello RJ, Bharani KL, Padmaraju V, Chopra N, Lahiri DK, Greig NH, Pappolla MA, Sambamurti K (2015) Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer\u2019s disease. Curr Alzheimer Res 12(1):32\u201346","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"2083_CR9","doi-asserted-by":"publisher","first-page":"e12679","DOI":"10.1111\/acel.12679","volume":"17","author":"J Lee","year":"2018","unstructured":"Lee J, Kim Y, Liu T, Hwang YJ, Hyeon SJ, Im H, Lee K, Alvarez VE et al (2018) SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer\u2019s disease. Aging Cell 17(1):e12679","journal-title":"Aging Cell"},{"issue":"1","key":"2083_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13024-019-0329-1","volume":"14","author":"RM Meade","year":"2019","unstructured":"Meade RM, Fairlie DP, Mason JM (2019) Alpha-synuclein structure and Parkinson\u2019s disease - lessons and emerging principles. Mol Neurodegener 14(1):29","journal-title":"Mol Neurodegener"},{"key":"2083_CR11","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3389\/fnagi.2019.00372","volume":"11","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zhang Y, Zhu K, Chi S, Wang C, Xie A (2020) Emerging role of sirtuin 2 in Parkinson\u2019s disease. Front Aging Neurosci 11:372","journal-title":"Front Aging Neurosci"},{"issue":"12","key":"2083_CR12","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nrn1806","volume":"6","author":"E Cattaneo","year":"2005","unstructured":"Cattaneo E, Zuccato C, Tartari M (2005) Normal huntingtin function: an alternative approach to Huntington\u2019s disease. Nat Rev Neurosci 6(12):919\u2013930","journal-title":"Nat Rev Neurosci"},{"issue":"20","key":"2083_CR13","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1093\/hmg\/ddq313","volume":"19","author":"D Yang","year":"2010","unstructured":"Yang D, Wang C-E, Zhao B, Li W, Ouyang Z, Liu Z, Yang H, Fan P et al (2010) Expression of Huntington\u2019s disease protein results in apoptotic neurons in the brains of cloned transgenic pigs. Hum Mol Genet 19(20):3983\u20133994","journal-title":"Hum Mol Genet"},{"key":"2083_CR14","unstructured":"Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R (2020) Features, evaluation and treatment coronavirus (COVID-19). In: Statpearls [Internet]. StatPearls"},{"issue":"6","key":"2083_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/brainsci7060063","volume":"7","author":"R Morigaki","year":"2017","unstructured":"Morigaki R, Goto S (2017) Striatal vulnerability in Huntington\u2019s disease: neuroprotection versus neurotoxicity. Brain Sci 7(6):63","journal-title":"Brain Sci"},{"issue":"4","key":"2083_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/antiox6040090","volume":"6","author":"D Burtenshaw","year":"2017","unstructured":"Burtenshaw D, Hakimjavadi R, Redmond EM, Cahill PA (2017) Nox, reactive oxygen species and regulation of vascular cell fate. Antioxidants 6(4):90","journal-title":"Antioxidants"},{"key":"2083_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/2105607","volume":"2019","author":"G Cenini","year":"2019","unstructured":"Cenini G, Lloret A, Cascella R (2019) Oxidative stress in neurodegenerative diseases: from a mitochondrial point of view. Oxidative Med Cell Longev 2019:1\u201318","journal-title":"Oxidative Med Cell Longev"},{"issue":"5","key":"2083_CR18","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/1873-3468.12902","volume":"592","author":"R Stefanatos","year":"2018","unstructured":"Stefanatos R, Sanz A (2018) The role of mitochondrial ROS in the aging brain. FEBS Lett 592(5):743\u2013758","journal-title":"FEBS Lett"},{"issue":"11","key":"2083_CR19","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/cdd.2013.103","volume":"20","author":"A Vessoni","year":"2013","unstructured":"Vessoni A, Filippi-Chiela E, Menck CF, Lenz G (2013) Autophagy and genomic integrity. Cell Death Differ 20(11):1444\u20131454","journal-title":"Cell Death Differ"},{"issue":"10","key":"2083_CR20","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1080\/15548627.2016.1205770","volume":"12","author":"J Zhao","year":"2016","unstructured":"Zhao J, Goldberg AL (2016) Coordinate regulation of autophagy and the ubiquitin proteasome system by MTOR. Autophagy 12(10):1967\u20131970","journal-title":"Autophagy"},{"issue":"1","key":"2083_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.advms.2015.09.003","volume":"61","author":"M W\u0105troba","year":"2016","unstructured":"W\u0105troba M, Szukiewicz D (2016) The role of sirtuins in aging and age-related diseases. Adv Med Sci 61(1):52\u201362","journal-title":"Adv Med Sci"},{"issue":"5","key":"2083_CR22","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1161\/CIRCRESAHA.111.246546","volume":"111","author":"M Abdellatif","year":"2012","unstructured":"Abdellatif M (2012) Sirtuins and pyridine nucleotides. Circ Res 111(5):642\u2013656","journal-title":"Circ Res"},{"key":"2083_CR23","doi-asserted-by":"crossref","unstructured":"Rajendran R, Garva R, Krstic-Demonacos M, Demonacos C (2011) Sirtuins: molecular traffic lights in the crossroad of oxidative stress, chromatin remodeling, and transcription. Biomed Res Int 2011","DOI":"10.1155\/2011\/368276"},{"issue":"38","key":"2083_CR24","doi-asserted-by":"publisher","first-page":"14447","DOI":"10.1073\/pnas.0803790105","volume":"105","author":"B-H Ahn","year":"2008","unstructured":"Ahn B-H, Kim H-S, Song S, Lee IH, Liu J, Vassilopoulos A, Deng C-X, Finkel T (2008) A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci 105(38):14447\u201314452","journal-title":"Proc Natl Acad Sci"},{"key":"2083_CR25","doi-asserted-by":"crossref","unstructured":"Zhao L, Cao J, Hu K, He X, Yun D, Tong T, Han L (2020) Sirtuins and their biological relevance in aging and age-related diseases. Aging and Disease: 0","DOI":"10.14336\/AD.2019.0820"},{"key":"2083_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/3693625","volume":"2018","author":"SD Viana","year":"2018","unstructured":"Viana SD, Reis F, Alves R (2018) Therapeutic use of mTOR inhibitors in renal diseases: advances, drawbacks, and challenges. Oxidative Med Cell Longev 2018:1\u201317","journal-title":"Oxidative Med Cell Longev"},{"issue":"11","key":"2083_CR27","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1158\/2159-8290.CD-15-0460","volume":"5","author":"P Liu","year":"2015","unstructured":"Liu P, Gan W, Chin YR, Ogura K, Guo J, Zhang J, Wang B, Blenis J et al (2015) PtdIns (3,4,5) P3-dependent activation of the mTORC2 kinase complex. Cancer Discov 5(11):1194\u20131209","journal-title":"Cancer Discov"},{"key":"2083_CR28","first-page":"1","volume":"2018","author":"Y Luo","year":"2018","unstructured":"Luo Y, Xu W, Li G, Cui W (2018) Weighing in on mTOR complex 2 signaling: the expanding role in cell metabolism. Oxidative Med Cell Longev 2018:1\u201315","journal-title":"Oxidative Med Cell Longev"},{"issue":"7432","key":"2083_CR29","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature11861","volume":"493","author":"SC Johnson","year":"2013","unstructured":"Johnson SC, Rabinovitch PS, Kaeberlein M (2013) mTOR is a key modulator of ageing and age-related disease. Nature 493(7432):338\u2013345","journal-title":"Nature"},{"issue":"2","key":"2083_CR30","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1124\/pr.117.015370","volume":"71","author":"TA Thibaudeau","year":"2019","unstructured":"Thibaudeau TA, Smith DM (2019) A practical review of proteasome pharmacology. Pharmacol Rev 71(2):170\u2013197","journal-title":"Pharmacol Rev"},{"key":"2083_CR31","volume-title":"Caloric restriction research: new perspectives on the biology of aging","author":"RM Anderson","year":"2018","unstructured":"Anderson RM, Le Couteur DG, de Cabo R (2018) Caloric restriction research: new perspectives on the biology of aging. Oxford University Press, New York"},{"issue":"2","key":"2083_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s12017-014-8288-8","volume":"16","author":"MI Lutz","year":"2014","unstructured":"Lutz MI, Milenkovic I, Regelsberger G, Kovacs GG (2014) Distinct patterns of sirtuin expression during progression of Alzheimer\u2019s disease. NeuroMolecular Med 16(2):405\u2013414","journal-title":"NeuroMolecular Med"},{"issue":"2","key":"2083_CR33","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3233\/JAD-131124","volume":"38","author":"Y-X Sun","year":"2014","unstructured":"Sun Y-X, Ji X, Mao X, Xie L, Jia J, Galvan V, Greenberg DA, Jin K (2014) Differential activation of mTOR complex 1 signaling in human brain with mild to severe Alzheimer\u2019s disease. J Alzheimers Dis 38(2):437\u2013444","journal-title":"J Alzheimers Dis"},{"key":"2083_CR34","doi-asserted-by":"crossref","unstructured":"Yang G, Humphrey SJ, Murashige DS, Francis D, Wang QP, Cooke KC, Neely GG, James DE (2019) RagC phosphorylation autoregulates mTOR complex 1. EMBO J 38 (3)","DOI":"10.15252\/embj.201899548"},{"issue":"3","key":"2083_CR35","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.cmet.2018.01.016","volume":"27","author":"C Carrico","year":"2018","unstructured":"Carrico C, Meyer JG, He W, Gibson BW, Verdin E (2018) The mitochondrial acylome emerges: proteomics, regulation by sirtuins, and metabolic and disease implications. Cell Metab 27(3):497\u2013512","journal-title":"Cell Metab"},{"issue":"3","key":"2083_CR36","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1124\/jpet.112.192138","volume":"342","author":"A Johri","year":"2012","unstructured":"Johri A, Beal MF (2012) Mitochondrial dysfunction in neurodegenerative diseases. J Pharmacol Exp Ther 342(3):619\u2013630","journal-title":"J Pharmacol Exp Ther"},{"key":"2083_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1042\/bse0520023","volume":"52","author":"I Scott","year":"2012","unstructured":"Scott I, Anderson KA, Hirschey MD (2012) Mitochondrial protein acetylation regulates metabolism. Essays Biochem 52:23\u201335","journal-title":"Essays Biochem"},{"issue":"1","key":"2083_CR38","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/cancers11010090","volume":"11","author":"GL Beretta","year":"2019","unstructured":"Beretta GL, Corno C, Zaffaroni N, Perego P (2019) Role of FoxO proteins in cellular response to antitumor agents. Cancers 11(1):90","journal-title":"Cancers"},{"issue":"5","key":"2083_CR39","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.3892\/ol.2017.5851","volume":"13","author":"X Wang","year":"2017","unstructured":"Wang X, Hu S, Liu L (2017) Phosphorylation and acetylation modifications of FOXO3a: independently or synergistically? Oncol Lett 13(5):2867\u20132872","journal-title":"Oncol Lett"},{"key":"2083_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.redox.2015.06.019","volume":"6","author":"L-O Klotz","year":"2015","unstructured":"Klotz L-O, S\u00e1nchez-Ramos C, Prieto-Arroyo I, Urb\u00e1nek P, Steinbrenner H, Monsalve M (2015) Redox regulation of FoxO transcription factors. Redox Biol 6:51\u201372","journal-title":"Redox Biol"},{"issue":"1","key":"2083_CR41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/cancers7010030","volume":"7","author":"SM Reed","year":"2015","unstructured":"Reed SM, Quelle DE (2015) p53 acetylation: regulation and consequences. Cancers 7(1):30\u201369","journal-title":"Cancers"},{"issue":"7","key":"2083_CR42","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3390\/ijms20071601","volume":"20","author":"P Gong","year":"2019","unstructured":"Gong P, Wang Y, Jing Y (2019) Apoptosis induction by histone deacetylase inhibitors in cancer cells: role of Ku70. Int J Mol Sci 20(7):1601","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2083_CR43","doi-asserted-by":"publisher","first-page":"13903","DOI":"10.1007\/s13277-016-5202-z","volume":"37","author":"M Hada","year":"2016","unstructured":"Hada M, Subramanian C, Andrews PC, Kwok RP (2016) Cytosolic Ku70 regulates Bax-mediated cell death. Tumor Biol 37(10):13903\u201313914","journal-title":"Tumor Biol"},{"key":"2083_CR44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pneurobio.2013.10.004","volume":"112","author":"S Ghavami","year":"2014","unstructured":"Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M, Christoffersson J, Chaabane W et al (2014) Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol 112:24\u201349","journal-title":"Prog Neurobiol"},{"issue":"12","key":"2083_CR45","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.tibs.2010.07.003","volume":"35","author":"E Verdin","year":"2010","unstructured":"Verdin E, Hirschey MD, Finley LW, Haigis MC (2010) Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem Sci 35(12):669\u2013675","journal-title":"Trends Biochem Sci"},{"key":"2083_CR46","first-page":"1","volume":"2019","author":"ML-H Huang","year":"2019","unstructured":"Huang ML-H, Chiang S, Kalinowski DS, Bae D-H, Sahni S, Richardson DR (2019) The role of the antioxidant response in mitochondrial dysfunction in degenerative diseases: cross-talk between antioxidant defense, autophagy, and apoptosis. Oxidative Med Cell Longev 2019:1\u201326","journal-title":"Oxidative Med Cell Longev"},{"key":"2083_CR47","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1017\/S146239941000150X","volume":"12","author":"DJ Bonda","year":"2010","unstructured":"Bonda DJ, Lee H-p, Kudo W, Zhu X, Smith MA, Lee H-g (2010) Pathological implications of cell cycle re-entry in Alzheimer disease. Expert Rev Mol Med 12:e19","journal-title":"Expert Rev Mol Med"},{"issue":"1","key":"2083_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2051-5960-1-3","volume":"1","author":"SC Yates","year":"2013","unstructured":"Yates SC, Zafar A, Hubbard P, Nagy S, Durant S, Bicknell R, Wilcock G, Christie S et al (2013) Dysfunction of the mTOR pathway is a risk factor for Alzheimer\u2019s disease. Acta Neuropathol Commun 1(1):3","journal-title":"Acta Neuropathol Commun"},{"issue":"7","key":"2083_CR49","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.freeradbiomed.2008.07.011","volume":"45","author":"L Chen","year":"2008","unstructured":"Chen L, Liu L, Huang S (2008) Cadmium activates the mitogen-activated protein kinase (MAPK) pathway via induction of reactive oxygen species and inhibition of protein phosphatases 2A and 5. Free Radic Biol Med 45(7):1035\u20131044","journal-title":"Free Radic Biol Med"},{"key":"2083_CR50","doi-asserted-by":"crossref","unstructured":"Ghosh R, Pattison JS (2018) Macroautophagy and chaperone-mediated autophagy in heart failure: the known and the unknown. Oxidative Med Cell Longev 2018","DOI":"10.1155\/2018\/8602041"},{"key":"2083_CR51","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.freeradbiomed.2019.11.021","volume":"146","author":"BR Pinho","year":"2020","unstructured":"Pinho BR, Duarte AI, Canas PM, Moreira PI, Murphy MP, Oliveira JM (2020) The interplay between redox signalling and proteostasis in neurodegeneration: in vivo effects of a mitochondria-targeted antioxidant in Huntington\u2019s disease mice. Free Radic Biol Med 146:372\u2013382","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"2083_CR52","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3390\/ijms20030725","volume":"20","author":"M Condello","year":"2019","unstructured":"Condello M, Pellegrini E, Caraglia M, Meschini S (2019) Targeting autophagy to overcome human diseases. Int J Mol Sci 20(3):725","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2083_CR53","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/15548627.2019.1598754","volume":"16","author":"JA Thayer","year":"2020","unstructured":"Thayer JA, Awad O, Hegdekar N, Sarkar C, Tesfay H, Burt C, Zeng X, Feldman RA et al (2020) The PARK10 gene USP24 is a negative regulator of autophagy and ULK1 protein stability. Autophagy 16(1):140\u2013153","journal-title":"Autophagy"},{"key":"2083_CR54","doi-asserted-by":"crossref","unstructured":"Alecu I, Bennett SA (2019) Dysregulated lipid metabolism and its role in \u03b1-synucleinopathy in Parkinson\u2019s disease. Front Neurosci 13","DOI":"10.3389\/fnins.2019.00328"},{"issue":"7113","key":"2083_CR55","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443(7113):787\u2013795","journal-title":"Nature"},{"key":"2083_CR56","first-page":"24","volume":"10","author":"Q Cai","year":"2016","unstructured":"Cai Q, Tammineni P (2016) Alterations in mitochondrial quality control in Alzheimer\u2019s disease. Front Cell Neurosci 10:24","journal-title":"Front Cell Neurosci"},{"issue":"21","key":"2083_CR57","first-page":"2003","volume":"8","author":"C Guo","year":"2013","unstructured":"Guo C, Sun L, Chen X, Zhang D (2013) Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res 8(21):2003\u20132014","journal-title":"Neural Regen Res"},{"issue":"23","key":"2083_CR58","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1093\/hmg\/ddr381","volume":"20","author":"MJ Calkins","year":"2011","unstructured":"Calkins MJ, Manczak M, Mao P, Shirendeb U, Reddy PH (2011) Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer\u2019s disease. Hum Mol Genet 20(23):4515\u20134529","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2083_CR59","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3390\/cells9010150","volume":"9","author":"Q Cai","year":"2020","unstructured":"Cai Q, Jeong YY (2020) Mitophagy in Alzheimer\u2019s disease and other age-related neurodegenerative diseases. Cells 9(1):150","journal-title":"Cells"},{"issue":"7","key":"2083_CR60","doi-asserted-by":"publisher","first-page":"e1820","DOI":"10.1038\/cddis.2015.166","volume":"6","author":"A Reeve","year":"2015","unstructured":"Reeve A, Ludtmann MH, Angelova P, Simcox E, Horrocks M, Klenerman D, Gandhi S, Turnbull D et al (2015) Aggregated \u03b1-synuclein and complex I deficiency: exploration of their relationship in differentiated neurons. Cell Death Dis 6(7):e1820\u2013e1820","journal-title":"Cell Death Dis"},{"issue":"1","key":"2083_CR61","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ (2018) Huntington\u2019s disease: a clinical review. Eur J Neurol 25(1):24\u201334","journal-title":"Eur J Neurol"},{"issue":"33","key":"2083_CR62","doi-asserted-by":"publisher","first-page":"16593","DOI":"10.1073\/pnas.1904101116","volume":"116","author":"S Yablonska","year":"2019","unstructured":"Yablonska S, Ganesan V, Ferrando LM, Kim J, Pyzel A, Baranova OV, Khattar NK, Larkin TM et al (2019) Mutant huntingtin disrupts mitochondrial proteostasis by interacting with TIM23. Proc Natl Acad Sci 116(33):16593\u201316602","journal-title":"Proc Natl Acad Sci"},{"issue":"19","key":"2083_CR63","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1101\/gad.227439.113","volume":"27","author":"L Guarente","year":"2013","unstructured":"Guarente L (2013) Calorie restriction and sirtuins revisited. Genes Dev 27(19):2072\u20132085","journal-title":"Genes Dev"},{"issue":"31","key":"2083_CR64","doi-asserted-by":"publisher","first-page":"21745","DOI":"10.1074\/jbc.M602909200","volume":"281","author":"W Qin","year":"2006","unstructured":"Qin W, Yang T, Ho L, Zhao Z, Wang J, Chen L, Zhao W, Thiyagarajan M et al (2006) Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 281(31):21745\u201321754","journal-title":"J Biol Chem"},{"issue":"5","key":"2083_CR65","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1021\/pr500192g","volume":"13","author":"Z Tang","year":"2014","unstructured":"Tang Z, Baykal AT, Gao H, Quezada HC, Zhang H, Bereczki E, Serhatli M, Baykal B et al (2014) mTor is a signaling hub in cell survival: a mass-spectrometry-based proteomics investigation. J Proteome Res 13(5):2433\u20132444","journal-title":"J Proteome Res"},{"key":"2083_CR66","doi-asserted-by":"crossref","unstructured":"Adav SS, Sze SK (2020) Hypoxia-induced degenerative protein modifications associated with aging and age-associated disorders. Aging and Disease: 0","DOI":"10.14336\/AD.2019.0604"},{"key":"2083_CR67","doi-asserted-by":"crossref","unstructured":"Schirinzi T, Martella G, Imbriani P, Di Lazzaro G, Franco D, Colona VL, Alwardat M, Salimei PS, Mercuri NB, Pierantozzi M (2019) Dietary vitamin E as a protective factor for Parkinson\u2019s disease: clinical and experimental evidence. Front Neurol 10","DOI":"10.3389\/fneur.2019.00148"},{"key":"2083_CR68","doi-asserted-by":"crossref","unstructured":"Eckert GP (2019) The role of vitamin E in aging and Alzheimer\u2019s disease. In: Vitamin E in human health. Springer, pp. 325\u2013344","DOI":"10.1007\/978-3-030-05315-4_24"},{"issue":"11","key":"2083_CR69","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1002\/mds.27120","volume":"32","author":"F Yang","year":"2017","unstructured":"Yang F, Wolk A, H\u00e5kansson N, Pedersen NL, Wirdefeldt K (2017) Dietary antioxidants and risk of Parkinson\u2019s disease in two population-based cohorts. Mov Disord 32(11):1631\u20131636","journal-title":"Mov Disord"},{"issue":"1","key":"2083_CR70","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1468-1331.2010.03088.x","volume":"18","author":"Y Miyake","year":"2011","unstructured":"Miyake Y, Fukushima W, Tanaka K, Sasaki S, Kiyohara C, Tsuboi Y, Yamada T, Oeda T et al (2011) Dietary intake of antioxidant vitamins and risk of Parkinson\u2019s disease: a case\u2013control study in Japan. Eur J Neurol 18(1):106\u2013113","journal-title":"Eur J Neurol"},{"issue":"12","key":"2083_CR71","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1002\/mds.26819","volume":"31","author":"KC Hughes","year":"2016","unstructured":"Hughes KC, Gao X, Kim IY, Rimm EB, Wang M, Weisskopf MG, Schwarzschild MA, Ascherio A (2016) Intake of antioxidant vitamins and risk of Parkinson\u2019s disease. Mov Disord 31(12):1909\u20131914","journal-title":"Mov Disord"},{"issue":"5","key":"2083_CR72","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1001\/jamaneurol.2016.5778","volume":"74","author":"RJ Kryscio","year":"2017","unstructured":"Kryscio RJ, Abner EL, Caban-Holt A, Lovell M, Goodman P, Darke AK, Yee M, Crowley J et al (2017) Association of antioxidant supplement use and dementia in the Prevention of Alzheimer\u2019s Disease by Vitamin E and Selenium Trial (PREADViSE). JAMA Neurol 74(5):567\u2013573","journal-title":"JAMA Neurol"},{"issue":"3","key":"2083_CR73","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1001\/archneurol.2011.30","volume":"68","author":"ML Evatt","year":"2011","unstructured":"Evatt ML, DeLong MR, Kumari M, Auinger P, McDermott MP, Tangpricha V (2011) High prevalence of hypovitaminosis D status in patients with early Parkinson disease. Arch Neurol 68(3):314\u2013319","journal-title":"Arch Neurol"},{"issue":"7","key":"2083_CR74","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1007\/s12035-016-0048-3","volume":"54","author":"L Naia","year":"2017","unstructured":"Naia L, Rosenstock TR, Oliveira AM, Oliveira-Sousa SI, Caldeira GL, Carmo C, La\u00e7o MN, Hayden MR et al (2017) Comparative mitochondrial-based protective effects of resveratrol and nicotinamide in Huntington\u2019s disease models. Mol Neurobiol 54(7):5385\u20135399","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2083_CR75","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/nyas.13431","volume":"1403","author":"C Sawda","year":"2017","unstructured":"Sawda C, Moussa C, Turner RS (2017) Resveratrol for Alzheimer\u2019s disease. Ann N Y Acad Sci 1403(1):142\u2013149","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"2083_CR76","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/jama.2013.282834","volume":"311","author":"MW Dysken","year":"2014","unstructured":"Dysken MW, Sano M, Asthana S, Vertrees JE, Pallaki M, Llorente M, Love S, Schellenberg GD et al (2014) Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA 311(1):33\u201344","journal-title":"JAMA"},{"key":"2083_CR77","doi-asserted-by":"crossref","unstructured":"Belitskaya\u2010L\u00e9vy I, Dysken M, Guarino P, Sano M, Asthana S, Vertrees JE, Pallaki M, Llorente M, Love S, Schellenberg G (2018) Impact of apolipoprotein E genotypes on vitamin E and memantine treatment outcomes in Alzheimer\u2019s disease. Alzheimer's & Dementia: Translational Research & Clinical Interventions 4:344\u2013349","DOI":"10.1016\/j.trci.2018.06.001"},{"issue":"2\u20133","key":"2083_CR78","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s12035-010-8111-y","volume":"41","author":"AY Sun","year":"2010","unstructured":"Sun AY, Wang Q, Simonyi A, Sun GY (2010) Resveratrol as a therapeutic agent for neurodegenerative diseases. Mol Neurobiol 41(2\u20133):375\u2013383","journal-title":"Mol Neurobiol"},{"key":"2083_CR79","first-page":"1","volume":"2014","author":"T Ma","year":"2014","unstructured":"Ma T, Tan M-S, Yu J-T, Tan L (2014) Resveratrol as a therapeutic agent for Alzheimer\u2019s disease. Biomed Res Int 2014:1\u201313","journal-title":"Biomed Res Int"},{"issue":"16","key":"2083_CR80","doi-asserted-by":"publisher","first-page":"6910","DOI":"10.1021\/jf8007212","volume":"56","author":"K-T Lu","year":"2008","unstructured":"Lu K-T, Ko M-C, Chen B-Y, Huang J-C, Hsieh C-W, Lee M-C, Chiou RY, Wung B-S et al (2008) Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. J Agric Food Chem 56(16):6910\u20136913","journal-title":"J Agric Food Chem"},{"issue":"1\u20133","key":"2083_CR81","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejphar.2008.10.005","volume":"600","author":"F Jin","year":"2008","unstructured":"Jin F, Wu Q, Lu Y-F, Gong Q-H, Shi J-S (2008) Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson\u2019s disease in rats. Eur J Pharmacol 600(1\u20133):78\u201382","journal-title":"Eur J Pharmacol"},{"issue":"19","key":"2083_CR82","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.2174\/1381612825666190717110932","volume":"25","author":"MH Pourhanifeh","year":"2019","unstructured":"Pourhanifeh MH, Shafabakhsh R, Reiter RJ, Asemi Z (2019) The effect of resveratrol on neurodegenerative disorders: Possible protective actions against autophagy, apoptosis, inflammation and oxidative stress. Curr Pharm Des 25(19):2178\u20132191","journal-title":"Curr Pharm Des"},{"issue":"1","key":"2083_CR83","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.biocel.2008.06.010","volume":"41","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB, Harikumar KB (2009) Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 41(1):40\u201359","journal-title":"Int J Biochem Cell Biol"},{"issue":"8","key":"2083_CR84","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1517\/13543784.2012.693479","volume":"21","author":"AS Darvesh","year":"2012","unstructured":"Darvesh AS, Carroll RT, Bishayee A, Novotny NA, Geldenhuys WJ, Van der Schyf CJ (2012) Curcumin and neurodegenerative diseases: a perspective. Expert Opin Investig Drugs 21(8):1123\u20131140","journal-title":"Expert Opin Investig Drugs"},{"key":"2083_CR85","doi-asserted-by":"crossref","unstructured":"Noguchi-Shinohara M, Hamaguchi T, Yamada M (2019) The potential role of curcumin in treatment and prevention for neurological disorders. In: Curcumin for neurological and psychiatric disorders. Elsevier, pp. 85\u2013103","DOI":"10.1016\/B978-0-12-815461-8.00005-0"},{"key":"2083_CR86","doi-asserted-by":"crossref","unstructured":"Elifani F, Amico E, Pepe G, Capocci L, Castaldo S, Rosa P, Montano E, Pollice A, Madonna M, Filosa S (2019) Curcumin dietary supplementation ameliorates disease phenotype in an animal model of Huntington\u2019s disease. Hum Mol Genet","DOI":"10.1093\/hmg\/ddz247"},{"issue":"1","key":"2083_CR87","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3233\/JAD-2011-110209","volume":"27","author":"M Dumont","year":"2011","unstructured":"Dumont M, Kipiani K, Yu F, Wille E, Katz M, Calingasan NY, Gouras GK, Lin MT et al (2011) Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer\u2019s disease. J Alzheimers Dis 27(1):211\u2013223","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"2083_CR88","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1212\/WNL.0000000000003478","volume":"88","author":"A McGarry","year":"2017","unstructured":"McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I et al (2017) A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology 88(2):152\u2013159","journal-title":"Neurology"},{"issue":"8","key":"2083_CR89","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1089\/ars.2014.5952","volume":"22","author":"N Apostolova","year":"2015","unstructured":"Apostolova N, Victor VM (2015) Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications. Antioxid Redox Signal 22(8):686\u2013729","journal-title":"Antioxid Redox Signal"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02083-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-020-02083-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02083-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T11:50:45Z","timestamp":1650541845000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-020-02083-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,31]]},"references-count":89,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2083"],"URL":"https:\/\/doi.org\/10.1007\/s12035-020-02083-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,31]]},"assertion":[{"value":"10 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}